Senolytic cocktail Dasatinib+Quercetin (D+Q) does not enhance the efficacy of senescence-inducing chemotherapy in liver cancer [Online resource]
author
Kovacovicova, Kristina
Školnaja, Marianna
Heinmaa, Mihkel
Mistrik, Martin
Pata, Pille
Pata, Illar
statement of authorship
Kristina Kovacovicova, Marianna Skolnaja, Mihkel Heinmaa, Martin Mistrik, Pille Pata, Illar Pata, Jiri Bartek and Manlio Vinciguerra
source
Frontiers in oncology
journal volume number month
vol. 8
year of publication
2018
pages
art. 459, 7 p. : ill
url
https://doi.org/10.3389/fonc.2018.00459
subject term
maksahaigused
ravimiarendus
keyword
NAFLD (non-alcoholic fatty liver disease)
HCC (hepatocellular carcinoma)
senolytic agents
quercertin
dasatinib
ISSN
2234-943X
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
https://www.scopus.com/sourceid/21100275443
https://www.scopus.com/record/display.uri?eid=2-s2.0-85061031003&origin=inward&txGid=a986780eba711fe4d206578628861c4b
WOS
https://jcr.clarivate.com/jcr-jp/journal-profile?journal=FRONT%20ONCOL&year=2022
https://www.webofscience.com/wos/woscc/full-record/WOS:000448674200001
category (general)
Medicine
Biochemistry, genetics and molecular biology
Meditsiin
Biokeemia, geneetika ja molekulaarbioloogia
category (sub)
Medicine. Oncology
Biochemistry, genetics and molecular biology. Cancer research
Meditsiin. Onkoloogia
Biokeemia, geneetika ja molekulaarbioloogia. Vähiuuringud
quartile
Q1
TalTech department
keemia ja biotehnoloogia instituut
language
inglise
Reserch Group
Laboratory of biofunctional materials
Microfluidics group